AI assistant
Sending…
IRIDEX CORP — Director's Dealing 2014
Aug 2, 2014
34978_dirs_2014-08-01_9f2a2309-00bd-4228-857f-8de33cb7d491.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-07-31
Reporting Person: Steckel Ronald (VP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-31 | Common Stock | M | 761 | $3.99 | Acquired | 2725 | Direct |
| 2014-07-31 | Common Stock | S | 761 | $8.00 | Disposed | 1964 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-31 | Stock Option Right to Buy | $3.99 | M | 761 | Disposed | 2016-04-16 | Common Stock (761) | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Selling Plan adopted by the reporting person on 3/5/13.
F2: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
F3: The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
More from IRIDEX CORP
Interim / Quarterly Report
2026
May 19
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 28